NeoImmuneTech (XKRX:950220) Net Change in Cash : ₩-48,907.88 Mil (TTM As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is NeoImmuneTech Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

NeoImmuneTech's Net Change in Cash for the three months ended in Dec. 2023 was ₩-6,585.22 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2023 was ₩-48,907.88 Mil.

NeoImmuneTech Net Change in Cash Historical Data

The historical data trend for NeoImmuneTech's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NeoImmuneTech Net Change in Cash Chart

NeoImmuneTech Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Net Change in Cash

53,613.38

-24,773.79

76,651.58

-49,263.15

-48,907.88

NeoImmuneTech Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Net Change in Cash	Get a 7-Day Free Trial											-1,611.27	-14,984.30	-14,889.59	-12,448.78	-6,585.22

NeoImmuneTech Net Change in Cash Calculation

NeoImmuneTech's Net Change in Cash for the fiscal year that ended in Dec. 2023 is calculated as

Net Change in Cash	=	Cash Flow from Operations	+	Cash Flow from Investing	+	Cash Flow from Financing	+	Effect of Exchange Rate Changes
	=	-49760.75	+	2086.887	+	-1136.482	+	-97.535
	=	-48,907.88

NeoImmuneTech's Net Change in Cash for the quarter that ended in Dec. 2023

Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes

= -7839.154 + 621.129 + -272.084 + 904.89

= -6,585.22

Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-48,907.88 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NeoImmuneTech Net Change in Cash Related Terms
Thank you for viewing the detailed overview of NeoImmuneTech's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

NeoImmuneTech (XKRX:950220) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NeoImmuneTech Inc (XKRX:950220) » Definitions » Net Change in Cash

Comparable Companies

XKRX:215380 XKRX:322970 XKRX:343090 XKRX:283100 XKRX:446440 XKRX:072520 XKRX:251280 XKRX:179530 XKRX:344860 XKRX:208340 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX

Traded in Other Exchanges

N/A

Address

2400 Research Boulevard, Suite 250, Rockville, MD, USA, 20850

Website

http://www.neoimmunetech.com

NeoImmuneTech Inc is a clinical-stage T cell-focused biotech company dedicated to the discovery and development of novel immuno-therapeutics. Its lead asset NT-I7 is the clinical stage IL-7, which enhances the body's immune function to address key resistance mechanisms in Immuno-Oncology and deadly infectious diseases.

NeoImmuneTech (XKRX:950220) Headlines

No Headlines